Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma

Authors: Obermair, Andreas ^{a, ⁎}, Gebski, Val ^b, Goh, Jeffrey ^c, Kuchel, Anna ^{c, d}, Brand, Alison ^{e, f}, Mak, Blossom ^{b, e}, McNally, Orla ^{g, h, i}, Baxter, Eva ^a, Jobling, Thomas ^{j, k}, Mileshkin, Linda ⁱ

Source: In International Journal of Gynecological Cancer April 2025 35(4)

Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy

Authors: Cabrit, Nicolas ^{a, q}, Cheugoua-Zanetsie, Maurice ^{a, b, q}, Tierney, Jayne ^{c, q}, Thirion, Pierre ^{d, q}, Nankivell, Matthew ^{e, q}, Winter, Kathryn ^{f, q}, Yang, Hong ^{g, q}, Wijnhoven, Bas ^{h, q}, Vernerey, Dewi ^{i, q}, Smithers, B.Mark ^{j, q}, Piessen, Guillaume ^{k, q}, Nilsson, Magnus ^{l, q}, Boonstra, Jurjen ^{m, q}, Ychou, Marc ^{n, q}, Law, Simon ^{o, q}, Cunningham, David ^{p, q}, Vathaire, Florent de ^{a, q}, Stahl, Michael ^{q, r}, Urba, Susan ^{q, s}, Valmasoni, Michele ^{q, t}, Williaume, Danièle ^{q, u}, Thomas, Janine ^{q, v}, Lordick, Florian ^{q, w}, Tepper, Joel ^{q, x}, Gebski, Val ^{q, y}, Burmeister, Bryan ^{q, t}, Paoletti, Xavier ^{q, z}, Sandick, Johanna van ^{aa, q}, Fu, Jianhua ^{f, q}, Pignon, Jean-Pierre ^{a, b, q}, Ducreux, Michel ^{ab, q}, Faron, Matthieu ^{a, q, 1}, Michiels, Stefan ^{a, b, q, ⁎, 1}

Source: In European Journal of Cancer 11 March 2025 218

Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trial

Authors: Virili, Florencia ^{a, b}, Obermair, Andreas ^{c, d, ⁎}, Sanjida, Saira ^e, Nicklin, James L. ^d, Garrett, Andrea ^c, Land, Russell ^c, Tang, Amy ^c, Campbell, Louise ^f, Gebski, Val ^g, Thomas, Paul ^{h, i}

Source: In International Journal of Gynecological Cancer August 2024

Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer

Authors: Francis, Katherine Elizabeth ^{a, b, ⁎}, Simon, Sandy ^a, Gebski, Val ^a, Joly, Florence ^{c, d}, Ledermann, Jonathan A. ^e, Penson, Richard T. ^f, Oza, Amit M. ^g, Korach, Jacob ^h, Lainez, Nuria ⁱ, Cecere, Sabrina Chiara ^j, Tasca, Giulia ^k, Gropp-Meier, Martina ^{l, m}, Fujiwara, Keiichi ⁿ, Lowe, Elizabeth S. ^o, Friedlander, Michael ^{p, q}, Pujade-Lauraine, Eric ^r, Lee, Chee Khoon ^{a, s}

Source: In Gynecologic Oncology January 2025 192:50-55

Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup

Authors: Barretina-Ginesta, Pilar, Bennett, Katherine, Berek, Jonathan, Berger, Regina, Bjørge, Line, Boere, Ingrid, Brennan, Donal, Bruchim, Ilan, Chang, Ting-Chang, Chavez Blanco, Adriana, Chen, Xiaojun, Colombo, Nicoletta, Crosbie, Emma, Denys, Hannelore, Duska, Linda, Fruehauf, Filip, Gomez Garcia, Eva Maria, van Gorp, Toon, Grimm, Christoph, Guitmann, Gustavo, Han, Kathy, Hanker, Lars, Harano, Kenichi, Hasegawa, Kosei, Herrington, C Simon, Ip, Philip, Joly, Florence, Khaw, Pearly, Kohn, Elise, Kristeleit, Rebecca, Kroep, Judith, Leary, Alexandra, Lee, Jung-Yun, Lheureux, Stephanie, Liu, Jihong, Mackay, Helen, Mahner, Sven, Mariani, Andrea, McAlpine, Jessica, Mikami, Yoshiki, Mirza, Mansoor Raza, Mukhopadhyay, Asima, Nagao, Shoji, Ng, Joseph, Nogueira-Rodrigues, Angelica, Novák, Zoltán, O'Donnell, Jennifer, Osborne, Sherill, Perez-Fidalgo, J. Alejandro, Romeo Marin, Margarita, Roy Chowdhury, Rahul, Sadozye, Azmat, Safra, Tamar, Scott, Claire, Sehouli, Jalid, Slomovitz, Brian, Tan, David, Taylor, Alexandra, Valabrega, Giorgio, Veneziani, Ana, Verhoeven, Karen, Vetter, Marcus, Wampfler, Julian, Westin, Shannon, Wimberger, Pauline, Zola, Paolo, Creutzberg, Carien L ^{*, *}, Kim, Jae-Weon ^*, Eminowicz, Gemma, Allanson, Emma, Eberst, Lauriane, Kim, Se Ik, Nout, Remi A, Park, Jeong-Yeol, Lorusso, Domenica, Mileshkin, Linda, Ottevanger, Petronella B, Brand, Alison, Mezzanzanica, Delia, Oza, Amit, Gebski, Val, Pothuri, Bhavana, Batley, Tania ^†, Gordon, Carol ^†, Mitra, Tina ^†, White, Helen ^†, Howitt, Brooke, Matias-Guiu, Xavier, Ray-Coquard, Isabelle, Gaffney, David, Small, William, Jr, Miller, Austin, Concin, Nicole, Powell, Matthew A, Stuart, Gavin, Bookman, Michael A

Source: In The Lancet Oncology September 2024 25(9):e420-e431

Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): primary results of a prospective two-arm study

Authors: Mann, Gregory Bruce ^*, Skandarajah, Anita Rohini, Zdenkowski, Nicholas, Hughes, Janemary, Park, Allan, Petrie, Dennis, Saxby, Karinna, Grimmond, Sean M, Murugasu, Anand, Spillane, Andrew J, Chua, Boon H, Badger, Heath, Braggett, Helen, Gebski, Val, Mou, Arlene, Collins, John P, Rose, Allison K

Source: In The Lancet 20-26 January 2024 403(10423):261-270

10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection

Authors: Campbell, Ian, Wetzig, Neil, Ung, Owen, Espinoza, David, Farshid, Gelareh, Collins, John, Kollias, James, Gebski, Val, Mister, Rebecca, Simes, R. John, Stockler, Martin R., Gill, Grantley

Source: In The Breast August 2023 70:70-75

The impact of surgical complications on obstetricians’ and gynecologists’ well-being and coping mechanisms as second victims

Authors: Collings, Rachel ^a, Potter, Christian ^b, Gebski, Val ^c, Janda, Monika ^d, Obermair, Andreas ^{e, ∗}

Source: In American Journal of Obstetrics and Gynecology January 2025 232(1):104-104

Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 study

Authors: Carroll, Robert P ^*, Boyer, Michael, Gebski, Val, Hockley, Bronwyn, Johnston, Julie K, Kireta, Svjetlana, Tan, Hsiang, Taylor, Anne, Wyburn, Kate, Zalcberg, John R

Source: In The Lancet Oncology August 2022 23(8):1078-1086

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

Authors: Mahner, Sven, Reuss, Alexander, du Bois, Andreas, Grimm, Christoph, Marth, Christian, Berger, Regina, Concin, Nicole, Chang, Ting-Chang, Ochiai, Kazunori, Gebski, Val, Davis, Alison, Beale, Philip, Vergote, Ignace, Kridelka, Frédéric, Denys, Hannelore, Vandecaveye, Vincent, Candido dos Reis, Francisco Jose, Del Pilar Estevez Diz, Maria, Stuart, Gavin, MacKay, Helen, Carey, Mark, Cibula, David, Dundr (path), Pavel, Dorigo, Oliver, Berek, Jonathan, O'Donnell, Dearbhaile, Saadeh, Abu, Boere, Ingrid, Lok, Christianne, Coronado, Pluvio, Ottevanger, Nelleke, Tan, David SP, Ng, Joseph, Gonzalez Martin, Antonio, Oaknin, Ana, Poveda, Andres, Perez Fidalgo, Alejandro, Rauh-Hain, Alejandro, Lu, Karen, López-Zavala, Carlos, Gómez-García, Eva María, Ray-Coquard, Isabelle, Paoletti, Xavier, Kurtz, Jean-Emmanuel, Joly, Florence, Votan, Bénédicte, Bookman, Michael, Moore, Kathleen, Arend, Rebecca, Fujiwara, Keiichi, Fujiwara, Hiroyuki, Hasegawa, Kosei, Bruchim, Ilan, Tsoref, Dalia, Oda, Katsutoshi, Okamoto, Aikou, Enomoto, Takayuki, Michel, Dayana, Kim, Hee-Seung, Lee, Jung-Yun, Mukhopadhyay, Asima, Katsaros, Dionyssios, Colombo, Nicoletta, Pignata, Sandro, Lorusso, Domenica, Scambia, Giovanni, Kohn, Elise, Lee, Jung-Min, McNeish, Iain, Nicum, Shibani, Farrelly, Laura, Sehouli, Jalid, Keller, Maren, Braicu, Elena, Bjørge, Line, Mirza, Mansoor Raza, Auranen, Annika, Welch, Stephen, Oza, Amit M, Heinzelmann, Viola, Gourley, Charlie, Roxburgh, Patricia, Herrington, C Simon, Glasspool, Ros, Zang, Rongyu, Zhu, Jianqing, Gonzalez-Martin, Antonio, Kohn, Elise C, Berek, Jonathan S, Tan, David S P, Stuart, Gavin C E, Bookman, Michael A

Source: In The Lancet Oncology August 2022 23(8):e374-e384

AGITG ASCEND: Randomised, double-blind phase II study of certepetide or placebo added to gemcitabine plus nab-paclitaxel in patients with untreated metastatic pancreatic ductal adenocarcinoma: Initial results.

Authors: Dean, Andrew Peter, Sjoquist, Katrin, Gebski, Val, Karapetis, Christos Stelios, Lomma, Chris, Burge, Matthew E., Steer, Christopher B., Tebbutt, Niall C, Lee, Belinda, Jackson, Christopher G. C. A., Day, Fiona, Padinharakam, Shamsudheen, Murray, James, Yip, Sonia, Mumford, Jan, Siu, Derrick HW, Lee, Joanna, Gao, Yan Ru, Harris, Marion, Price, Timothy Jay

Source: Journal of Clinical Oncology; 2025 Supplement 4, Vol. 43, p728-728, 121p

C‐reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients.

Authors: Bonazzi, Vanessa F., Aoude, Lauren G., Brosda, Sandra, Bradford, Julia J., Lonie, James M., Loffler, Kelly A., Gartside, Michael G., Patel, Kalpana, Mukhopadhyay, Pamela, Keane, Colm, Gebski, Val, Kench, James G., Goldstein, David, Waddell, Nicola, Barbour, Andrew P.

Source: Asia Pacific Journal of Clinical Oncology; Feb2025, Vol. 21 Issue 1, p77-86, 10p

Subject Terms: C-reactive protein, PROGNOSIS, BIOMARKERS, CANCER chemotherapy, IMMUNE response, PANCREATIC tumors, SURVIVAL rate, PANCREATIC cancer

Adverse events in the placebo arm of maintenance therapy trials in advanced ovarian cancer: A systematic review and meta-analysis

Authors: Simon, Sandy, Francis, Katherine E., Dalrymple, Janene E., Gebski, Val, Lord, Sarah J., Friedlander, Michael, Lee, Chee Khoon

Source: In European Journal of Cancer July 2022 170:169-178

Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer

Authors: Cohen, Paul A ^{1, 2, 3, *}, Webb, Penelope M ⁴, King, Madeleine ⁵, Obermair, Andreas ⁶, Gebski, Val ⁷, Butow, Phyllis ^{8, 9}, Morton, Rachael ⁷, Lawson, Wanda ¹⁰, Yates, Patsy ¹¹, Campbell, Rachel ⁵, Meniawy, Tarek ¹², McMullen, Michelle ¹², Dean, Andrew ¹³, Goh, Jeffrey ^{14, 15}, McNally, Orla ^{16, 17}, Mileshkin, Linda ^{18, 19}, Beale, Philip ²⁰, Beach, Rhonda ¹⁰, Hill, Jane ²¹, Dixon, Cyril ²¹, Hegarty, Sue ²¹, Codde, Jim ³, Ives, Angela ²², Lee, Yeh Chen ^{23, 24}, Brand, Alison ^{25, 26}, Mellon, Anne ²⁷, Bilic, Sanela ¹, Black, Isobel ¹, Jeffares, Stephanie ¹, Friedlander, Michael ^{23, 28}

Source: In International Journal of Gynecological Cancer April 2022 32(4):560-565

A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020

Authors: Obermair, Andreas ^{1, 2, 3, *}, Nicklin, Jim ¹, Gebski, Val ⁴, Hayes, Sandra C ⁵, Graves, Nicholas ⁶, Mileshkin, Linda ⁷, Lin, Ming Yin ⁸, Beale, Phillip ⁹, Baxter, Eva ¹, Robledo, Kristy ⁴, Salomon, Carlos ², Hanna, George B ¹⁰, Janda, Monika ¹¹

Source: In International Journal of Gynecological Cancer December 2021 31(12)

Individual patient data meta-analysis of neoadjuvant chemotherapy followed by surgery versus upfront surgery for carcinoma of the oesophagus or the gastro-oesophageal junction

Authors: Faron, Matthieu, Cheugoua-Zanetsie, Armel Maurice, Thirion, Pierre, Nankivell, Matthew, Winter, Kathryn, Cunningham, David, Van der Gaast, Ate, Law, Simon, Langley, Ruth, de Vathaire, Florent, Valmasoni, Michele, Mauer, Muriel, Roth, Jack, Gebski, Val, Burmeister, Bryan H., Paoletti, Xavier, van Sandick, Johanna, Fu, Jianhua, Ducreux, Michel, Blanchard, Pierre, Tierney, Jayne, Pignon, Jean-Pierre, Michiels, Stefan

Source: In European Journal of Cancer November 2021 157:278-290

Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy

Authors: Tjokrowidjaja, Angelina, Friedlander, Michael, Lord, Sarah J., Asher, Rebecca, Rodrigues, Manuel, Ledermann, Jonathan A., Matulonis, Ursula A., Oza, Amit M., Bruchim, Ilan, Huzarski, Tomasz, Gourley, Charlie, Harter, Philipp, Vergote, Ignace, Scott, Clare L., Meier, Werner, Shapira-Frommer, Ronnie, Milenkova, Tsveta, Pujade-Lauraine, Eric, Gebski, Val, Lee, Chee K.

Source: In European Journal of Cancer September 2021 154:190-200

Reporting the trajectories of adverse events over the entire treatment course in patients with recurrent platinum-sensitive ovarian cancer treated with platinum-based combination chemotherapy regimens: A graphical approach to trial adverse event reporting

Authors: Francis, Katherine E., Gebski, Val, Lord, Sarah J., Friedlander, Michael, Pujade-Lauraine, Eric, Lee, Chee Khoon

Source: In European Journal of Cancer May 2021 148:251-259

Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee

Authors: Kurtz, Jean-Emmanuel, Gebski, Val, Sukhin, Vladyslav, Carey, Mark, Kong, Iwa, Glasspool, Rosalind M., Berek, Jonathan S., de Paiva Batista, Mariana, Hall, Marcia, Kim, Jae-Weon, Yeoshoua, Effi, Fujiwara, Noriko, Nam, Byung-Ho, Polleis, Sandra, Lee, Jung-Yun, Strojna, Aleksandra, Farrelly, Laura, Schwameis, Richard, Fossati, Roldano, Darlington, Anne-Sophie, Lai, Chyong-Huey, Wright, Alexi A., Rosenblat, Orgad, Harter, Phillip, Roxburgh, Patricia, Chowdhury, Rahul Roy, Chang, Ting-Chang, Paoletti, Xavier, Friedlander, Michael

Source: In Gynecologic Oncology May 2021 161(2):502-507

Long-term quality of life outcomes of women treated for early-stage endometrial cancer

Authors: Sanjida, Saira ¹, Obermair, Andreas ², Gebski, Val ³, Armfield, Nigel ², Janda, Monika ^{1, *}

Source: In International Journal of Gynecological Cancer April 2021 31(4):530-536